发作性睡病

American Academy of Sleep Medicine. International classification of sleep disorders - third edition (ICSD-3). 2014 [Internet publication].

• 全文

Lim AS, Scammell TE. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep. 2010 Jul;33(7):857-8.

• 全文
• 摘要

Okun ML, Giese S, Lin L, et al. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun. 2004 Jul;18(4):326-32.

• 摘要

Wise MS, Arand DL, Auger RR, et al; American Academy of Sleep Medicine. Treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007 Dec;30(12):1712-27.

• 全文
• 摘要

Morgenthaler TI, Kapur VK, Brown T, et al; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007 Dec;30(12):1705-11.

• 全文
• 摘要

Golicki D, Bala MM, Niewada M, et al. Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit. 2010 Aug;16(8):RA177-86.

• 摘要

Alshaikh MK, Tricco AC, Tashkandi M, et al. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. J Clin Sleep Med. 2012 Aug 15;8(4):451-8.

• 全文
• 摘要

Boscolo-Berto R, Viel G, Montagnese S, et al. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2012 Oct;16(5):431-43.

• 摘要

1.  American Academy of Sleep Medicine. International classification of sleep disorders - third edition (ICSD-3). 2014 [Internet publication].

• 全文

2.  Berry BR, Gilmore RL. Narcolepsy and idiopathic hypersomnia. In: Carney PR, Berry RB, Geyer JD, eds. Clinical sleep disorders. Philadelphia, PA: Lippincot Williams and Wilkins; 2005.

3.  Rosen GM, Bendel AE, Neglia JP, et al. Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics. 2003 Jul;112(1 Pt 1):e46-54.

• 摘要

4.  Guilleminault C, Fromherz S. Narcolepsy: diagnosis and management. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005.

5.  Marcus CL, Trescher WH, Halbower AC, et al. Secondary narcolepsy in children with brain tumors. Sleep. 2002 Jun 15;25(4):435-9.

• 摘要

6.  Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology. 1996 Feb;46(2):393-401.

• 摘要

7.  Hublin C, Partinen M, Kaprio J, et al. Epidemiology of narcolepsy. Sleep. 1994 Dec;17(8 Suppl):S7-12.

• 摘要

8.  Silber MH, Krahn LE, Olson EJ, et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002 Mar 15;25(2):197-202.

• 摘要

9.  Zeman A, Britton T, Douglas N, et al. Narcolepsy and excessive daytime sleepiness. BMJ. 2004 Sep 25;329(7468):724-8.

• 摘要

10.  Ohayon MM, Priest RG, Zulley J, et al. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002 Jun 25;58(12):1826-33.

• 摘要

11.  Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep. 2002 Feb 1;25(1):27-35.

• 摘要

12.  Ebrahim IO, Peacock KW, Williams AJ. Posttraumatic narcolepsy - two case reports and a mini review. J Clin Sleep Med. 2005 Apr 15;(2)1:153-6.

• 摘要

13.  Silber MH. Narcolepsy, head injury, and the problem of causality. J Clin Sleep Med. 2005 Apr 15;1(2):157-8.

• 摘要

14.  Bruck D, Broughton RJ. Diagnostic ambiguities in a case of post-traumatic narcolepsy with cataplexy. Brain Inj. 2004 Mar;18(3):321-6.

• 摘要

15.  Scammell TE, Nishino S, Mignot E, et al. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology. 2001 Jun 26;56(12):1751-3.

• 摘要

16.  Bjornstad B, Goodman SH, Sirven JI, et al. Paroxysmal sleep as a presenting symptom of bilateral paramedian thalamic infarctions. Mayo Clin Proc. 2003 Mar;78(3):347-9.

• 摘要

17.  Rosenfeld MR, Eichen JG, Wade DF, et al. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol. 2001 Sep;50(3):339-48.

• 摘要

18.  Schwartz WJ, Stakes JW, Hobson JA. Transient cataplexy after removal of a craniopharyngioma. Neurology. 1984 Oct;34(10):1372-5.

• 摘要

19.  Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology. 1989 Nov;39(11):1505-8.

• 摘要

20.  Arii J, Kanbayashi T, Tanabe Y, et al. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor. Neurology. 2001 Jun 26;56(12):1775-6.

• 摘要

21.  Malik S, Boeve BF, Krahn LE, et al. Narcolepsy associated with other central nervous system disorders. Neurology. 2001 Aug 14;57(3):539-41.

• 摘要

22.  Gledhill RF, Bartel PR, Yoshida Y, et al. Narcolepsy caused by acute disseminated encephalomyelitis. Arch Neurol. 2004 May;61(5):758-60.

• 全文
• 摘要

23.  Rubinstein I, Gray TA, Moldofsky H, et al. Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest. 1988 July;94(1):205-6.

• 摘要

24.  Servan J, Marchand F, Garma L, et al. Narcolepsy disclosing neurosarcoidosis [in French]. Rev Neurol (Paris). 1995 Apr;151(4):281-3.

• 摘要

25.  Clavelou P, Tournilhac M, Vidal C, et al. Narcolepsy associated with arteriovenous malformation of the diencephalon. Sleep. 1995 Apr;18(3):202-5.

• 摘要

26.  Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol. 2005 Mar;25(1):64-8.

• 摘要

27.  Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004 Aug;127(pt 8):1831-44.

• 全文
• 摘要

28.  Landolfi JC, Nadkarni M. Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study. Neuro Oncol. 2003 Jul;5(3):214-6.

• 全文
• 摘要

29.  Overeem S, Dalmau J, Bataller L, et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology. 2004 Jan 13;62(1):138-40.

• 摘要

30.  Kandt RS, Emerson RG, Singer HS, et al. Cataplexy in variant forms of Niemann-Pick disease. Ann Neurol. 1982 Sept;12(3):284-8.

• 摘要

31.  Vankova J, Stepanova I, Jech R, et al. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. Sleep. 2003 Jun 15;26(4):427-430.

• 摘要

32.  Vossler DG, Wyler AR, Wilkus RJ, et al. Cataplexy and monoamine oxidase deficiency in Norrie disease. Neurology. 1996 May;46(5):1258-61.

• 摘要

33.  Manni R, Politini L, Nobili L, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001 May;112(5):800-5.

• 摘要

34.  Mignot E, Hayduk R, Black J, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997 Nov;20(11):1012-20.

• 摘要

35.  Hayduk R, Flodman P, Spence MA, et al. HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy. Sleep. 1997 Oct;20(10):850-7.

• 全文
• 摘要

36.  Taheri S, Mignot E. The genetics of sleep disorders. Lancet Neurol. 2002 Aug;1(4):242-50.

• 摘要

37.  Watson NF, Ton TG, Koepsell TD, et al. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep. 2010;33:29-35.

• 摘要

38.  Miyagawa T, Kawashima M, Nishida N, et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet. 2008;40:1324-1328.

• 摘要

39.  Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41:708-711.

• 摘要

40.  Miyagawa T, Honda M, Kawashima M, et al. Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype. J Hum Genet. 2010;55:63-65.

• 摘要

41.  Guilleminault C, Heinzer R, Mignot E, et al. Investigations into the neurologic basis of narcolepsy. Neurology. 1998 Feb;50(2 suppl 1):S8-15.

• 摘要

42.  Faull KF, Thiemann S, King RJ, et al. Monoamine interactions in narcolepsy and hypersomnia: reanalysis. Sleep. 1989 Apr;12(2):185-6.

• 摘要

43.  Faull KF, Barchas JD, Foutz AS, et al. Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs. Brain Res. 1982 Jun 17;242(1):137-43.

• 摘要

44.  Aldrich MS, Hollingsworth Z, Penney JB. Dopamine-receptor autoradiography of human narcoleptic brain. Neurology. 1992 Feb;42(2):410-5.

• 摘要

45.  Nishino S, Sakurai E, Nevsimalova S, et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep. 2009 Feb;32(2):175-180.

• 摘要

46.  Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep. 2009 Feb;32(2):181-7.

• 摘要

47.  Mignot E. Narcolepsy. In: Ioachimescu OC, ed. Contemporary sleep medicine for patients. Bentham Science; 2011 [e-book].

• 全文

48.  de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7.

• 全文
• 摘要

49.  Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998 Mar 6;92(5):697.

• 摘要

50.  Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002 Oct;59(10):1553-62.

• 全文
• 摘要

51.  Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 2001 Dec 26;57(12):2253-8.

• 摘要

52.  Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 Sept;6(9):991-7.

• 摘要

53.  Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000 Sep;27(3):469-74.

• 摘要

54.  Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep. 2009 Aug;32(8):993-8.

• 全文
• 摘要

55.  Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest. 2010;120:713-719.

• 全文
• 摘要

56.  Kawashima M, Lin L, Tanaka S, et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep. 2010 Jul;33(7):869-74.

• 全文
• 摘要

57.  Lim AS, Scammell TE. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep. 2010 Jul;33(7):857-8.

• 全文
• 摘要

58.  Toyoda H, Tanaka S, Miyagawa T, et al. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep. 2010 Jul;33(7):875-8.

• 全文
• 摘要

59.  Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep. 2009 Aug;32(8):979-83.

• 摘要

60.  Longstreth WT Jr, Ton TG, Koepsell TD. Narcolepsy and streptococcal infections. Sleep. 2009 Dec;32(12):1548.

• 摘要

61.  Okun ML, Giese S, Lin L, et al. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun. 2004 Jul;18(4):326-32.

• 摘要

62.  Hohjoh H, Nakayama T, Ohashi J, et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens. 1999 Aug;54(2):138-45.

• 摘要

63.  Himmerich H, Beitinger PA, Fulda S, et al. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch Intern Med. 2006 Sep 18;166(16):1739-43.

• 全文
• 摘要

64.  Hohjoh H, Terada N, Kawashima M, et al. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens. 2000 Nov;56(5):446-8.

• 摘要

65.  Dauvilliers Y, Carlander B, Rivier F, et al. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004 Dec;56(6):905-8.

• 摘要

66.  Dauvilliers Y, Abril B, Mas E, et al. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009 Oct 26;73(16):1333-4.

• 摘要

67.  Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998 Feb;50(2 suppl 1):S16-22.

• 摘要

68.  Fronczek R, Lammers GJ, Balesar R, et al. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab. 2005 Sep;90(9):5466-50.

• 全文
• 摘要

69.  Schüle B, Albalwi M, Northrop E, et al. Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome. BMC Med Genet. 2005 May 6;6:18.

• 全文
• 摘要

70.  Richdale AL, Cotton S, Hibbit K. Sleep and behaviour disturbance in Prader-Willi syndrome: a questionnaire study. J Intellect Disabil Res. 1999 Oct;43(pt 5):380-92.

• 摘要

71.  Smit LS, Lammers GJ, Catsman-Berrevoets CE. Cataplexy leading to the diagnosis of Niemann-Pick disease type C. Pediatr Neurol. 2006 Jul;35(1):82-4.

• 摘要

72.  Miyake S, Inoue H, Ohtahara S, et al. A case of Niemann-Pick disease type C with narcolepsy syndrome [In Japanese]. Rinsho Shinkeigaku. 1983 Jan;23(1):44-52.

• 摘要

73.  Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000 Jan 1;355(9197):39-40.

• 摘要

74.  Nakayama J, Miura M, Honda M, et al. Linkage of human narcolepsy with HLA association to chromosome 4p13-q21. Genomics. 2000 Apr 1;65(1):84-6.

• 摘要

75.  Miyagawa T, Hohjoh H, Honda Y, et al. Identification of a telomeric boundary of the HLA region with potential for predisposition to human narcolepsy. Immunogenetics. 2000 Nov;52(1-2):12-18.

• 摘要

76.  Dauvilliers Y, Blouin JL, Neidhart E, et al. A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q. Ann Neurol. 2004 Sep;56(3):382-8.

• 摘要

77.  Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5.

• 摘要

78.  Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992 Aug;15(4):376-81.

• 摘要

79.  Chasens ER, Williams LL, Umlauf MG. Excessive sleepiness. In: Capezuti E, Zwicker D, Mezey M, et al, eds. Evidence-based geriatric nursing protocols for best practice. 3rd ed. New York, NY: Springer; 2009:459-476.

80.  Broughton R, Dunham W, Newman J, et al. Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls. Electroencephalogr Clin Neurophysiol. 1988 Dec;70(6):473-81.

• 摘要

81.  Dantz B, Edgar DM, Dement WC. Circadian rhythms in narcolepsy: studies on a 90 minute day. Electroencephalogr Clin Neurophysiol. 1994 Jan;90(1):24-35.

• 摘要

82.  Guilleminault C, Gelb M. Clinical aspects and features of cataplexy. Adv Neurol. 1995;67:65-77.

• 摘要

83.  Anic-Labat S, Guilleminault C, Kraemer HC, et al. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep. 1999 Feb 1;22(1):77-87.

• 摘要

84.  Littner M, Johnson SF, McCall WV, et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep. 2001 Jun 15;24(4):451-66.

• 摘要

85.  Harsh J, Peszka J, Hartwig G, et al. Night-time sleep and daytime sleepiness in narcolepsy. J Sleep Res. 2000 Sep;9(3):309-16.

• 摘要

86.  Mayer G, Meier-Ewert K. Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?). J Sleep Res. 1993 Sep;2(3):143-8.

• 摘要

87.  Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992 Jul;32(1):3-10.

• 摘要

88.  Aldrich MS, Chervin RD, Malow BA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep. 1997 Aug;20(8):620-9.

• 摘要

89.  Amira SA, Johnson TS, Logowitz NB. Diagnosis of narcolepsy using the multiple sleep latency test: analysis of current laboratory criteria. Sleep. 1985 Dec;8(4):325-31.

• 摘要

90.  Roehrs T, Roth T. Multiple sleep latency test: technical aspects and normal values. J Clin Neurophysiol. 1992 Jan;9(1):63-7.

• 摘要

91.  Mignot E, Lin L, Finn L, et al. Correlates of sleep-onset REM periods during the multiple sleep latency test in community adults. Brain. 2006 Jun;129(Pt 6):1609-23.

• 全文
• 摘要

92.  Dauvilliers Y, Gosselin A, Paquet J, et al. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology. 2004 Jan 13;62(1):46-50.

• 摘要

93.  Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol. 2003 Nov;114(11):2000-17.

• 摘要

94.  Overeem S, Scammell TE, Lammers GJ. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol. 2002 Dec;15(6):739-45.

• 摘要

95.  Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005 Apr;28(4):499-521.

• 全文
• 摘要

96.  Morgenthaler T, Alessi C, Friedman L, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007 Apr;30(4):519-29.

• 摘要

97.  Carskadon MA, Dement WC, Mitler MM, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986 Dec;9(4):519-24.

• 摘要

98.  Chervin RD, Aldrich MS. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):426-31.

• 全文
• 摘要

99.  Krahn LE, Pankratz VS, Oliver L, et al. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep. 2002 Nov 1;25(7):733-6.

• 摘要

100.  Miyagawa T, Kawamura H, Obuchi M, et al. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial. PLoS One. 2013;8(1):e53707.

• 全文
• 摘要

101.  Dauvilliers Y, Bassetti C, Lammers GJ, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 2013 Nov;12(11):1068-75.

• 摘要

102.  Weinhold SL, Seeck-Hirschner M, Nowak A, et al. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res. 2014 Apr 1;262:8-13.

• 摘要

103.  Lopez R, Dauvilliers Y. Pharmacotherapy options for cataplexy. Expert Opin Pharmacother. 2013 May;14(7):895-903.

• 摘要

104.  Andlauer O, Moore H, Jouhier L, et al. Nocturnal REM sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurol. 2013 Jul;70(7):891-902.

• 全文
• 摘要

105.  Wise MS, Arand DL, Auger RR, et al; American Academy of Sleep Medicine. Treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007 Dec;30(12):1712-27.

• 全文
• 摘要

106.  Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother. 2010 Jul;11(10):1633-45.

• 摘要

107.  Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 1998 Feb;50(2 suppl 1):S31-6.

• 摘要

108.  Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry. 1976 Jun;128:562-5.

• 摘要

109.  Mullington J, Broughton R. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy. Sleep. 1993 Aug;16(5):444-56.

• 摘要

110.  Rogers AE, Aldrich MS, Lin X. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep. 2001 Jun 15;24(4):385-91.

• 摘要

111.  Mitler MM, Aldrich MS, Koob GF, et al. Narcolepsy and its treatment with stimulants. ASDA standards of practice. Sleep. 1994 Jun;17(4):352-71.

• 摘要

112.  Boutrel B, Koob GF. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep. 2004 Sep 15;27(6):1181-94.

• 摘要

113.  Morgenthaler TI, Kapur VK, Brown T, et al; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007 Dec;30(12):1705-11.

• 全文
• 摘要

114.  Golicki D, Bala MM, Niewada M, et al. Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit. 2010 Aug;16(8):RA177-86.

• 摘要

115.  Bogan RK. Armodafinil in the treatment of excessive sleepiness. Expert Opin Pharmacother. 2010 Apr;11(6):993-1002.

• 摘要

116.  Brown JN, Wilson DT. Safety and efficacy of armodafinil in the treatment of excessive sleepiness. Clin Med Insights Ther. 2011;3:159-69.

• 全文

117.  Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep 2006 Jul;29(7):939-46.

• 摘要

118.  Black J, Pardi D, Hornfeldt CS, et al. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Sleep Medicine. 2009 Sep;10(8):829-35.

• 摘要

119.  Black J, Pardi D, Hornfeldt CS, et al. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy. J Clin Sleep Med. 2010 Dec 15;6(6):596-602.

• 全文
• 摘要

120.  Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 2003 Feb;53(2):154-66.

• 摘要

121.  Vignatelli L, D'Alessandro R, Candelise L. Antidepressant drugs for narcolepsy. Cochrane Database Syst Rev. 2008;(1):CD003724.

• 全文
• 摘要

122.  Alshaikh MK, Tricco AC, Tashkandi M, et al. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. J Clin Sleep Med. 2012 Aug 15;8(4):451-8.

• 全文
• 摘要

123.  Boscolo-Berto R, Viel G, Montagnese S, et al. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2012 Oct;16(5):431-43.

• 摘要

124.  Boivin DB, Montplaisir J, Petit D, et al. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol. 1993 Feb;16(1):46-53.

• 摘要

125.  Miller MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep. 1993 Jun;16(4):306-17.

• 全文
• 摘要

126.  Arand D, Bonnet M, Hurwitz T, et al. The clinical use of the MSLT and MWT. Sleep. 2005 Jan;28(1):123-44.

• 摘要